Advisor Group Holdings, Inc. Summit Therapeutics Inc. Transaction History

Advisor Group Holdings, Inc.

  • $67.1 Billion
  • Q3 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 5,493 shares of SMMT stock, worth $100,192. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,493
Previous 6,064 9.42%
Holding current value
$100,192
Previous $129,000 12.4%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$17.61 - $30.02 $10,055 - $17,141
-571 Reduced 9.42%
5,493 $113,000
Q2 2025

Sep 04, 2025
SELL
$16.64 - $36.7 $150,958 - $332,942
-9,072 Reduced 59.94%
6,064 $129,000
Q2 2025

Aug 13, 2025
BUY
$16.64 - $36.7 $51,467 - $113,513
3,093 Added 25.68%
15,136 $322,000
Q1 2025

May 12, 2025
SELL
$16.65 - $23.76 $1,964 - $2,803
-118 Reduced 0.97%
12,043 $232,000
Q4 2024

Jun 06, 2025
BUY
$17.52 - $23.46 $25,999 - $34,814
1,484 Added 12.32%
13,527 $241,000
Q4 2024

Feb 07, 2025
BUY
$17.52 - $23.46 $2,137 - $2,862
122 Added 1.01%
12,161 $217,000
Q3 2024

Nov 13, 2024
BUY
$6.89 - $31.93 $79,848 - $370,036
11,589 Added 2575.33%
12,039 $263,000
Q2 2024

Aug 13, 2024
SELL
$2.39 - $10.92 $27,272 - $124,608
-11,411 Reduced 96.21%
450 $3,000
Q1 2024

May 10, 2024
SELL
$2.55 - $5.07 $336,842 - $669,721
-132,095 Reduced 91.76%
11,861 $49,000
Q4 2023

Feb 12, 2024
SELL
$1.67 - $2.83 $42,788 - $72,510
-25,622 Reduced 15.11%
143,956 $375,000
Q3 2023

Nov 13, 2023
BUY
$1.54 - $2.42 $1,848 - $2,904
1,200 Added 0.71%
169,578 $317,000
Q2 2023

Aug 10, 2023
BUY
$1.32 - $2.81 $16,907 - $35,993
12,809 Added 8.23%
168,378 $422,000
Q1 2023

May 12, 2023
BUY
$1.38 - $5.41 $150,965 - $591,826
109,395 Added 236.92%
155,569 $272,000
Q4 2022

Feb 10, 2023
BUY
$0.68 - $5.31 $3,944 - $30,797
5,800 Added 14.37%
46,174 $196,000
Q3 2022

Nov 14, 2022
BUY
$0.89 - $1.63 $26,498 - $48,531
29,774 Added 280.89%
40,374 $48,000
Q2 2022

Aug 10, 2022
BUY
$0.92 - $2.38 $920 - $2,380
1,000 Added 10.42%
10,600 $11,000
Q1 2022

May 04, 2022
SELL
$2.0 - $3.45 $2,960 - $5,106
-1,480 Reduced 13.36%
9,600 $24,000
Q3 2021

Nov 05, 2021
BUY
$4.83 - $8.27 $24,633 - $42,177
5,100 Added 85.28%
11,080 $56,000
Q2 2021

Aug 02, 2021
BUY
$5.15 - $8.46 $30,797 - $50,590
5,980 New
5,980 $44,000

Others Institutions Holding SMMT

# of Institutions
266
Shares Held
94.2M
Call Options Held
4.72M
Put Options Held
4.03M
View Full List

About Summit Therapeutics Inc.

SMMT Quotes by TradingView
  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.67B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email